Valirx Plc (VALX)

London
54.5000
-1.0000(-1.83%)
  • Volume:
    7,223,930
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    54.5000 - 54.5000

VALX Overview

Prev. Close
54.75
Day's Range
54.5-54.5
Revenue
-
Open
55.5
52 wk Range
17.26-57.85
EPS
-0.02
Volume
7,223,930
Market Cap
35.45M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,033,142
P/E Ratio
-
Beta
2.97
1-Year Change
124.74%
Shares Outstanding
65,049,156
Next Earnings Date
24 Apr 2022
What is your sentiment on Valirx Plc?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralBuyStrong BuyNeutral
Technical IndicatorsSellStrong SellStrong BuyStrong BuyStrong Buy
SummaryNeutralSellStrong BuyStrong BuyBuy

Valirx Plc Company Profile

Valirx Plc Company Profile

Employees
10

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. It operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.

Read More
  • Waiter to Diner....And how would you like your shorter Sir, well done or burnt
    0
    • I think they are looking close to sealing a deal for their Val 201. Certainly before the end of year.
      0
  • Things definately  hotting up in the Val sector
    0
    • About what?
      2
      • any news?
        0
        • Does anyone think ValiRx can ever recover to its formwr glory days? Even anything over £1??
          0
          • https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
            1
            • check out Aim Listed DeepMatter Ltd
              0
              • shite
                0
            • high risk high reward
              0
              • A train wreck in progress here...massive dilution time and again.
                2
                • This didn't age well.
                  0
              • Please correct the bid/ask price. It’s been incorrect for weeks. Thanks
                0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.